From Medicineworld.org: New Model Of Prostate Cancer
Cancer blog: I manage the cancer blog with lots of help and support form other bloggers. Through this cancer blog my friends and I try to bring stories of hope for patients with cancer. The cancer blog often republishes important blog posts from other cancer related blogs at Medicineworld.org. If you are searching for a blog that covers wide variety of cancer topics, this may be the one for you.
Breast cancer blog: Breast cancer blog is run by Emily and other bloggers and they bring you the latest stories, news and events that are related to breast cancer. Increasing awareness about breast cancer among women and in the general population is the main goal of this breast cancer blog.
Lung cancer blog: Lung cancer blog is managed by Scott with the help of other bloggers. Through this blog Scott and his friends constantly remind the readers about the dangers of smoking. It's a never-ending struggle against this miserable disease with which a social stigma of smoking is associated.
Colon cancer blog: Colon cancer blog is run by Sue and other bloggers. Sue brings a personal touch to the colon cancer blog since her mother died of colon cancer few years ago. She writes about stories, research news and advances in treatment related to colon cancer.
Prostate cancer blog: Prostate cancer is the most common cancer among American men. American Cancer Society estimates that over 230,000 new cases of prostate cancer occur in the United state every year. This important blog about prostate cancer is run by Mark and other bloggers. This blog brings news, stories, and other personal observations related to prostate cancer.
Medicineworld.org publishes a diabetes watch blog and this blog is run by JoAnn other bloggers. This diabetes watch blog brings you the latest in the field of diabetes. This includes personal stories, advances in diagnosis and treatment, and other observations about diabetes. Improving awareness about diabetes is an important mission of this group.
New Model Of Prostate Cancer
Thomas J. RosolScientists have developed a new line of prostate cancer cells that they hope will provide a better model to study the disease.
This new cancer-cell line has already provided some help. One new study in mice identified a promising possible treatment to reduce skeletal pain that accompanies prostate cancer. Researchers found that a substance called anti-nerve growth factor appeared to be more effective in controlling pain in mice than even morphine.
But the work would not have been possible without the new cell line, said Tom Rosol , a co-author of study and a professor of veterinary medicine at Ohio State University.
Armed with this new cell line, researchers will be able to more directly study how prostate cancer affects the body, said Rosol, whose laboratory developed the cell line.
Metastatic bone tumors are a common manifestation in patients with late-stage breast cancer or prostate cancer. "Metastasis" means that cancer has spread from its original site to other areas of the body. But breast cancer typically destroys bone at tumor sites, whereas prostate cancer tumors that spread to bone induce abnormal bone growth.
Currently, most models used to study prostate cancer do not mimic the human condition and the resulting bone metastases. Most of these models really mimic the spread of breast cancer since the bone metastases in that disease are associated with bone loss rather than bone growth.
"Even though there is more bone at the sites of prostate cancer tumors, this formation still damages the bone," said Rosol, who is also dean of the College of Veterinary Medicine at Ohio State . "The new growth compresses nerves, making it terribly painful for the patient".
The results appear in a January issue of the journal Cancer Research. The study was led by Patrick Mantyh, a professor of preventive sciences at the University of Minnesota.
Only two mammals are known to develop prostate cancer -- men and dogs. Rosol's laboratory created a cell line from prostate tumors that had developed in a dog's bones. The scientists call this line of cells ACE-1.
In the current study, scientists at the University of Minnesota injected the ACE-1 cells directly into the femurs, or thigh bones, of male mice. These mice were specially bred to lack an immune system, leaving them vulnerable to developing prostate cancer. While the femur is the biggest bone in the body -- and therefore the easiest to study in this case -- prostate cancer can affect any bone in the body.
It took about a week for the prostate tumors to develop in the mice. At that point, the scientists began treating mice with anti-nerve growth factor (NGF). Anti-NGF is a molecule that naturally occurs in the body, where it promotes the survival and growth of nerves. An additional group of mice was treated with morphine. Control mice, which also had prostate cancer, were given a sterile saline solution instead of either anti-NGF or morphine.
The scientists wanted to know what kind of effect, if any, anti-NGF had on pain-related behaviors, tumor growth, bone formation and bone destruction in the mice.
The scientists watched mice at different points in the study to see if they showed any kind of pain-related behavior. The scientists kept track of how much time each mouse spent favoring its affected leg - how often the mouse lifted its leg while standing still, and for how long it held this leg aloft.
Mice treated with anti-NGF spent less time favoring their affected leg than did mice that were given morphine. In some cases, the time that a mouse treated with anti-NGF spent favoring its affected leg was half that of a mouse treated with morphine.
This suggests that anti-NGF treatment may be effective in reducing pain, thereby helping to enhance the quality of life in patients with bone pain caused by prostate cancer.
All of the animals were euthanized about two weeks after receiving the first round of ACE-1 injections. At that point, the scientists removed the affected thigh bone from each mouse in order to analyze the bone's density. Bone density corresponded with the number of tumors in the bone - the denser the bone, the more tumors it had.
Results from the density analysis showed that anti-NGF treatment did not stop prostate cancer from progressing, nor did it decrease bone formation caused by the disease.
Why prostate cancer causes excess bone to form remains a mystery, but having the ACE-1 model may help scientists learn why it happens.
"Bone is often the only clinically detectable site of the spread of prostate cancer," Rosol said. "Understanding why this happens is not only important for cancer patients, but also for researchers who are trying to understand how bone responds to different biochemical factors".
Rosol conducted the study with scientists from the University of Minnesota; the Veterans Affairs Medical Center in Minneapolis; and with Rinat Neuroscience Corporation, in Palo Alto, Calif.
This work was supported by a grant from the National Institutes of Health, the MinCREST program at the University of Minnesota and a Merit Review from the Veterans Administration.
Source: Ohio State University
Did you know?
Scientists have developed a new line of prostate cancer cells that they hope will provide a better model to study the disease. This new cancer-cell line has already provided some help. One new study in mice identified a promising possible treatment to reduce skeletal pain that accompanies prostate cancer. Researchers found that a substance called anti-nerve growth factor appeared to be more effective in controlling pain in mice than even morphine.
Medicineworld.org: New Model Of Prostate Cancer
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.